Evolution Wealth Advisors, LLC Argenx Se Transaction History

Evolution Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 28, 2022	SELL	$272.01 - $353.03 $8,160 - $10,590	-30 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$295.0 - $350.58 $13,275 - $15,776	-45 Reduced 60.0%	30 $9,000
Q2 2021 Jul 22, 2021	BUY	$257.11 - $319.92 $1,028 - $1,279	4 Added 5.63%	75 $23,000
Q1 2021 Apr 20, 2021	BUY	$268.3 - $380.31 $6,707 - $9,507	25 Added 54.35%	71 $20,000
Q4 2020 Feb 02, 2021	BUY	$248.13 - $308.36 $11,413 - $14,184	46 New	46 $14,000

400

30.9M

376K

489K

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $34.8B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.